455 related articles for article (PubMed ID: 31605750)
1. The potential and controversy of targeting STAT family members in cancer.
Verhoeven Y; Tilborghs S; Jacobs J; De Waele J; Quatannens D; Deben C; Prenen H; Pauwels P; Trinh XB; Wouters A; Smits ELJ; Lardon F; van Dam PA
Semin Cancer Biol; 2020 Feb; 60():41-56. PubMed ID: 31605750
[TBL] [Abstract][Full Text] [Related]
2. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
3. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance.
Sabaawy HE; Ryan BM; Khiabanian H; Pine SR
Carcinogenesis; 2021 Dec; 42(12):1411-1419. PubMed ID: 34415330
[TBL] [Abstract][Full Text] [Related]
4. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
Groner B; von Manstein V
Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
[TBL] [Abstract][Full Text] [Related]
5. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.
Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ
Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms and consequences of Jak-STAT signaling in the immune system.
Villarino AV; Kanno Y; O'Shea JJ
Nat Immunol; 2017 Mar; 18(4):374-384. PubMed ID: 28323260
[TBL] [Abstract][Full Text] [Related]
7. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
Yang X; Tang Z; Zhang P; Zhang L
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
[TBL] [Abstract][Full Text] [Related]
8. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
Tzeng HT; Chyuan IT; Lai JH
Biochem Pharmacol; 2021 Nov; 193():114760. PubMed ID: 34492272
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent.
Alunno A; Padjen I; Fanouriakis A; Boumpas DT
Cells; 2019 Aug; 8(8):. PubMed ID: 31443172
[TBL] [Abstract][Full Text] [Related]
10. Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer.
Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
J Clin Lab Anal; 2022 Apr; 36(4):e24315. PubMed ID: 35244291
[TBL] [Abstract][Full Text] [Related]
11. The JAK/STAT signaling cascade in gastric carcinoma (Review).
Khanna P; Chua PJ; Bay BH; Baeg GH
Int J Oncol; 2015 Nov; 47(5):1617-26. PubMed ID: 26398764
[TBL] [Abstract][Full Text] [Related]
12. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
13. The prognostic values of signal transducers activators of transcription family in ovarian cancer.
Li S; Sheng B; Zhao M; Shen Q; Zhu H; Zhu X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28536310
[TBL] [Abstract][Full Text] [Related]
14. Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.
Morgan EL; Macdonald A
Viruses; 2020 Sep; 12(9):. PubMed ID: 32899142
[TBL] [Abstract][Full Text] [Related]
15. Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma.
Wang X; Liao X; Yu T; Gong Y; Zhang L; Huang J; Yang C; Han C; Yu L; Zhu G; Qin W; Liu Z; Zhou X; Liu J; Han Q; Peng T
Int J Oncol; 2019 Oct; 55(4):805-822. PubMed ID: 31485610
[TBL] [Abstract][Full Text] [Related]
16. Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy.
Bose S; Banerjee S; Mondal A; Chakraborty U; Pumarol J; Croley CR; Bishayee A
Cells; 2020 Jun; 9(6):. PubMed ID: 32545187
[TBL] [Abstract][Full Text] [Related]
17. The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.
Goropevšek A; Holcar M; Avčin T
Clin Rev Allergy Immunol; 2017 Apr; 52(2):164-181. PubMed ID: 27216430
[TBL] [Abstract][Full Text] [Related]
18. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
Lai SY; Johnson FM
Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303
[TBL] [Abstract][Full Text] [Related]
19. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.
Zhao R; Hu Z; Zhang X; Huang S; Yu G; Wu Z; Yu W; Lu J; Ruan B
Cell Commun Signal; 2024 Jan; 22(1):68. PubMed ID: 38273295
[TBL] [Abstract][Full Text] [Related]
20. JAK-STAT core cancer pathway: An integrative cancer interactome analysis.
Erdogan F; Radu TB; Orlova A; Qadree AK; de Araujo ED; Israelian J; Valent P; Mustjoki SM; Herling M; Moriggl R; Gunning PT
J Cell Mol Med; 2022 Apr; 26(7):2049-2062. PubMed ID: 35229974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
